1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Local Ablative Therapy (LAT): new trials by email Literature Review of Local Ablative Therapy (LAT) trials Research Report on Local Ablative Therapy (LAT)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib Blood samples for Hematology, Blood samples for Chemistry, Blood sample for liver function tests - NSCLC | Phase 2 | Recruiting | Groupe Francais De Pneumo-Cancerologie | 45 | 2025-06-19 | 2026-04-29 |
| Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib osimertinib, Local Ablative Therapy (LAT) - Lung Adenocarcinoma, Lung Neoplasms | Phase 2 | Completed | National Cancer Institute (NCI) | 37 | 2016-04-13 | 2024-06-07 |
Lung Neoplasms (2) · Adenocarcinoma of Lung (1)
Groupe Francais De Pneumo-Cancerologie (1) · National Cancer Institute (NCI) (1)
France (1) · United States (1)